Breast cancer care compared with clinical Guidelines: an observational study in France

被引:18
|
作者
Lebeau, Marie [2 ]
Mathoulin-Pelissier, Simone [1 ,3 ,4 ,5 ]
Bellera, Carine [3 ,4 ]
Tunon-de-Lara, Christine [6 ]
Daban, Alain [2 ]
Lipinski, Francis [7 ]
Jaubert, Dominique [1 ]
Ingrand, Pierre [2 ]
Migeot, Virginie [2 ]
机构
[1] Reseau Cancerol Aquitaine, F-33076 Bordeaux, France
[2] CHU Poitiers, Serv Radiotherapie, Poitiers, France
[3] CRLCC Inst Bergonie, Unite Rech & Epidemiol Clin, F-33076 Bordeaux, France
[4] INSERM, CIC EC7, F-33076 Bordeaux, France
[5] Univ Victor Segalen Bordeaux 2, F-33076 Bordeaux, France
[6] CRLCC Inst Bergonie, Serv Chirurg, F-33076 Bordeaux, France
[7] Ctr Oncoradiotherapie Cote Basque, Bayonne, France
关键词
STAGE; QUALITY; WOMEN; IMPLEMENTATION; RADIOTHERAPY; MANAGEMENT; CARCINOMA;
D O I
10.1186/1471-2458-11-45
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Great variability in breast cancer (BC) treatment practices according to patient, tumour or organisation of care characteristics has been reported but the relation between these factors is not well known. In two French regions, we measured compliance with Clinical Practice Guidelines for non-metastatic BC care management and identified factors associated with non-compliance at clinical and organisational levels. Methods: Eligible patients had invasive unilateral BC without distant metastases and at least two contacts with one of the two regional healthcare systems (2003-2004) in the first year after diagnosis. Medical data were collected from patient medical records in all public and private hospitals (99 hospitals). The care process was defined by 20 criteria: clinical decisions for treatment and therapeutic procedures. Each criterion was classified according to level of compliance ("Compliant", "Justifiable" and "Not Compliant") and factors of non-compliance were identified (mixed effect logistic regression). Results: 926 women were included. Non-compliance with clinical decisions for treatment was associated with older patient age (OR 2.1; 95%CI: 1.3-3.6) and region (OR 3.0; 95%CI: 1.2-7.4). Non-compliance with clinical decisions for radiotherapy was associated with lymph node involvement or the presence of peritumoural vascular invasion (OR 1.5; 95%CI: 1.01-2.3) and non-compliance with overall treatment (clinical decisions for treatment + therapeutic procedures) was associated with the presence of positive lymph nodes (OR 2.0; 95%CI: 1.2-3.3), grade III versus grade I (OR 2.9; 95%CI: 1.4-6.2), and one region of care versus another (OR 3.5; 95%CI: 1.7-7.1). Finally, heterogeneity of compliance in overall treatment sequence was identified between local cancer units (p < 0.05). Conclusion: This study provides interesting insights into factors of non-compliance in non-metastatic BC management and could lead to quality care improvements.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] SEOM clinical guidelines for the treatment of metastatic breast cancer
    Alvarez Lopez, Isabel
    de la Haba Rodriguez, Juan
    Ruiz Simon, Amparo
    Bellet Ezquerra, Meritxell
    Calvo Martinez, Lourdes
    Garcia Estevez, Laura
    Rodriguez Lescure, Alvaro
    Isla Casado, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (11): : 719 - 723
  • [42] BRCA in breast cancer: ESMO Clinical Practice Guidelines
    Balmana, J.
    Diez, O.
    Rubio, I.
    Castiglione, M.
    ANNALS OF ONCOLOGY, 2010, 21 : v20 - v22
  • [43] Clinical practice guidelines: breast cancer pain - Response
    Levine, ML
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 167 (01) : 15 - 15
  • [44] Breast cancer - developing clinical guidelines for England and Wales
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 68 - 69
  • [45] SEOM clinical guidelines in Hereditary Breast and ovarian cancer
    G. Llort
    I. Chirivella
    R. Morales
    R. Serrano
    A. Beatriz Sanchez
    A. Teulé
    E. Lastra
    J. Brunet
    J. Balmaña
    B. Graña
    Clinical and Translational Oncology, 2015, 17 : 956 - 961
  • [46] Clinical Practice Guidelines for Breast Cancer: Current Limitations
    Lueftner, Diana
    BREAST JOURNAL, 2015, 21 (04): : 450 - 453
  • [47] SEOM clinical guidelines in metastatic breast cancer 2015
    J. Gavilá
    S. Lopez-Tarruella
    C. Saura
    M. Muñoz
    M. Oliveira
    L. De la Cruz-Merino
    S. Morales
    I. Alvarez
    J. A. Virizuela
    M. Martin
    Clinical and Translational Oncology, 2015, 17 : 946 - 955
  • [48] Clinical practice guidelines for the care and treatment of breast cancer: Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update)
    Scarth, H
    Cantin, J
    Levine, M
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 167 (02) : 154 - 155
  • [49] SEOM clinical guidelines in Hereditary Breast and ovarian cancer
    Llort, G.
    Chirivella, I.
    Morales, R.
    Serrano, R.
    Beatriz Sanchez, A.
    Teule, A.
    Lastra, E.
    Brunet, J.
    Balmana, J.
    Grana, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 956 - 961
  • [50] SEOM clinical guidelines for the treatment of early breast cancer
    Sonia del Barco Berrón
    Eva Ciruelos Gil
    Ignacio Tusquets Trías de Bes
    Montserrat Muñoz Mateu
    Pedro Sánchez Rovira
    Álvaro Rodríguez Lescure
    Dolores Isla Casado
    Clinical and Translational Oncology, 2010, 12 : 711 - 718